Summary
Definition
History and exam
Key diagnostic factors
- shoulder/hip girdle stiffness
- shoulder/hip girdle pain
- rapid response to corticosteroids
Other diagnostic factors
- acute onset
- low-grade fever
- anorexia
- weight loss
- malaise
- depression
- asthenia
- oligoarticular arthritis
Risk factors
- age ≥50 years
- giant cell arteritis (GCA)
- female sex
Diagnostic tests
1st tests to order
- erythrocyte sedimentation rate (ESR)
- C-reactive protein (CRP)
- CBC
Tests to consider
- TSH
- ultrasound
- MRI
- serum protein electrophoresis
- serum creatine phosphokinase
- rheumatoid factor
- anti-cyclic citrullinated peptide antibodies
Emerging tests
- interleukin (IL)-6
- fluorodeoxyglucose F-18 PET scan
Treatment algorithm
initial presentation
treatment-resistant or relapse or disease exacerbation
Contributors
Authors
Ari Weinreb, MD, PhD
Associate Chief of Rheumatology
VA Greater Los Angeles Healthcare System
Associate Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles
CA
Disclosures
AW declares that he has no competing interests.
Acknowledgements
Dr Ari Weinreb would like to gratefully acknowledge Dr Lynell Newmarch, a previous contributor to this topic.
Disclosures
LN declares that she has no competing interests.
Peer reviewers
Brian F. Mandell, MD, PhD, FACR
Vice Chairman of Medicine for Education
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Editor in Chief
Cleveland Clinic Journal of Medicine
Cleveland Clinic
Cleveland
OH
Declarações
BFM declares that he has no competing interests.
Kuntal Chakravarty, FRCP (London), FRCP (Glasgow), FRCP (Ireland), FACP (USA), FACR (USA)
Consultant Rheumatologist
BHRT University Hospital
Queen’s Hospital
Romford
UK
Declarações
KC declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Nothnagl T, Leeb BF. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica. Drugs Aging. 2006;23:391-402. Resumo
Buttgereit F, Dejaco C, Matteson EL, et al. Polymyalgia rheumatica and giant cell arteritis: A systematic review. JAMA. 2016 Jun 14;315(22):2442-58. Resumo
Dejaco C, Singh YP, Perel P, et al; European League Against Rheumatism; American College of Rheumatology. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheumatol. 2015;67:2569-2580.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Giant cell arteritis (GCA)
- Early rheumatoid arthritis (RA)
- Hypothyroidism
Mais Diagnósticos diferenciaisDiretrizes
- 2022 guideline for the prevention and treatment of glucocorticoid induced osteoporosis
- 2022 guideline for vaccinations in patients with rheumatic and musculoskeletal disease
Mais DiretrizesFolhetos informativos para os pacientes
Polymyalgia rheumatica
Mais Folhetos informativos para os pacientesVideos
Venepuncture and phlebotomy: animated demonstration
Mais vídeos
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal